Elizabeth A. Lafleur, Ph.D.
Affiliations: | 2003 | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Immunology, OncologyGoogle:
"Elizabeth Lafleur"Parents
Sign in to add mentor| Eugenie S. Kleinerman | grad student | 2003 | The University of Texas Graduate School of Biomedical Sciences at Houston | |
| (IL -12 inhibits the metastatic potential of osteosarcoma cells and induces tumor regression via a mechanism involving Fas /Fas ligand pathway.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhou Z, Lafleur EA, Koshkina NV, et al. (2005) Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity. Molecular Cancer Research : McR. 3: 685-91 |
| Lafleur EA, Koshkina NV, Stewart J, et al. (2004) Increased Fas expression reduces the metastatic potential of human osteosarcoma cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 8114-9 |
| Duan X, Zhou Z, Jia SF, et al. (2004) Interleukin-12 enhances the sensitivity of human osteosarcoma cells to 4-hydroperoxycyclophosphamide by a mechanism involving the Fas/Fas-ligand pathway. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 777-83 |
| Worth LL, Lafleur EA, Jia SF, et al. (2002) Fas expression inversely correlates with metastatic potential in osteosarcoma cells. Oncology Reports. 9: 823-7 |
| Lafleur EA, Jia SF, Worth LL, et al. (2001) Interleukin (IL)-12 and IL-12 gene transfer up-regulate Fas expression in human osteosarcoma and breast cancer cells. Cancer Research. 61: 4066-71 |